Evidence that microglia C3aR1 produces maladaptive alterations in response to neurogenic injury suggests that C3aR1 could be a potential therapeutic target for chronic pain management61 and that C3ar1 is implicated in the development of Th2 and asthma pathogenesis.59 Here, C3AR1 is linked to asthma.